NCT05353309

Brief Summary

Atherosclerosis can cause the arteries to narrow (stenosis) or clog (occlude), leading to reduced blood flow. Arteriography or angiography is a radiological examination of the arteries which will make it possible to confirm and quantify the severity of the damage to the artery and which, in certain cases, can be directly treated by angioplasty with or without stenting (selective angioplasty). Digital subtraction angiography (DSA), the reference technique, provides good image quality. The fluoroscopy used today during angioplasty procedures makes it possible to obtain images in real time and to guide the progression of the endovascular material in the arterial axis. Image fusion is an established technique for the endovascular treatment of aortic aneurysms. The feasibility of image fusion for the iliac arterial axes has already been assessed and is reproducible. However, there is no assessment of the irradiation rate in iliac angioplasty, using intraoperative image fusion, compared to standard angioplasty practices.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
350

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 25, 2021

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 29, 2022

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
Last Updated

April 29, 2022

Status Verified

April 1, 2022

Enrollment Period

2.4 years

First QC Date

April 5, 2022

Last Update Submit

April 28, 2022

Conditions

Keywords

irradiation patient rateiliac angioplasty

Outcome Measures

Primary Outcomes (1)

  • Irradiation rate

    mean irradiation rate during iliac angioplasty will be compared between the 2 study groups The primary endpoint of the research is the patient's intraoperative irradiation rate defined by measuring the dose area product (DAP) in Gy.cm2

    "immedialtely at the end of surgery procedure"

Study Arms (2)

Angioplasty DSA

ACTIVE COMPARATOR

Reference procedure (DSA), comprising: production of fluoroscopy images for placement of endoluminal material and navigation, subtracted angiography with placement of flaps to reduce the field of rays ("collimation ") for visualization of the arterial axis (in low dose, pulsed with maximum collimation), the realization of possible oblique incidences (external iliac), the catheterization with or without placement of a post-inflation stent, then the realization of a second subtracted control angiogram.

Procedure: Standard Angioplasty

Angioplasty DSA+Fusion

EXPERIMENTAL

Procedure under study (DSA+Fusion), including: production of fluoroscopy images for placement of the endoluminal material and navigation, 2 fluoroscopy images specifically for image fusion registration (from the images scanner), selective angiography under fluoroscopy with collimation to improve registration (in low dose mode, pulsed with maximum collimation), if possible no oblique views (3D markers of the fusion), with or without placement of post-inflation stent followed by subtracted control angiography

Procedure: Angioplasty with D images

Interventions

Angioplasty Iliac done following standard practice

Angioplasty DSA

Angioplasty Iliac under additional 3D Images merged as surgery support

Angioplasty DSA+Fusion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient, male or female, over the age of 18
  • Patient with a primary and/or external iliac lesion (TASC A, B and C)
  • Patient for whom unilateral angioplasty is indicated
  • Affiliated patient or beneficiary of a social security scheme
  • Patient having been informed and having signed a written consent.

You may not qualify if:

  • Patient with a BMI strictly less than 18.5 or greater than or equal to 30.0 kg/m²
  • Patient with long iliac thrombosis (including the primitive iliac and the external iliac)
  • Patient with a known allergy to iodine
  • Patient with a contraindication related to the procedure
  • Patient for whom a bilateral iliac procedure is indicated
  • Patient requiring an associated infra-inguinal endovascular procedure
  • Patient participating in another clinical study
  • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
  • Pregnant, breastfeeding or parturient women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU de Nantes

Nantes, Brittany Region, 44093, France

RECRUITING

Saint Martin Private Hospital

Caen, Normandy, 14050, France

RECRUITING

MeSH Terms

Interventions

Angioplasty

Intervention Hierarchy (Ancestors)

CatheterizationTherapeuticsEndovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresInvestigative Techniques

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2022

First Posted

April 29, 2022

Study Start

May 25, 2021

Primary Completion

September 30, 2023

Study Completion

September 30, 2023

Last Updated

April 29, 2022

Record last verified: 2022-04

Locations